New Study Evaluates the Use of Drug-Coated Balloons
January 19, 2022
RALEIGH, N.C. (January 19, 2022) – Dr. Saroj Neupane is serving as the principal investigator for a new clinical trial designed to evaluate the effectiveness of a new drug-coated balloon for patients with in-stent stenosis.
WakeMed Heart & Vascular was recently the first site in North Carolina to enroll a patient in this important new study for patients who have had prior stenting of a coronary artery and need revascularization due to restenosis.
As the first drug-coated balloon to be used in coronary arteries, this is a ground-breaking trial that can impact future therapeutic options. Congratulations, Dr. Neupane!
About WakeMed Health & Hospitals
Serving the community since 1961, WakeMed is a not-for-profit health care system founded and based in Raleigh, N.C. WakeMed exists to improve the health and well-being of our community by providing outstanding and compassionate care to all. WakeMed’s 976-bed system comprises a network of facilities throughout the Triangle area, including three full-service hospitals, seven emergency departments, a dedicated Children’s Hospital and Rehabilitation Hospital, more than 80 physician offices and Wake County’s only Level I Trauma Center. WakeMed’s mission-driven team includes more than 10,000 employees, 1,500 volunteers and 1,300 affiliated physicians, along with the more than 580 physicians and providers with WakeMed Physician Practices – all representing the best minds and the biggest hearts and the finest quality in health care and community health. For more information, visit www.wakemed.org or follow WakeMed on Facebook, Twitter and Instagram.
# # #